(Q39673279)

13 September 2017

title

Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors (English)

1 reference

13 September 2017

1

Idit Sagiv-Barfi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674367

14 June 2024

2

Ester Weiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20674367

14 June 2024

author name string

Alexander Levitzki

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

8 July 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0968089610006474?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

https://api.elsevier.com/content/article/PII:S0968089610006474?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Bioorganic & Medicinal Chemistry

14 June 2024

published in

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

17

1 reference

13 September 2017

page(s)

6404-6413

1 reference

Management of opportunistic infections in solid-organ transplantation

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Immunosuppressive drugs: the first 50 years and a glance forward

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

An evidence-based update on nonsteroidal anti-inflammatory drugs

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

STUDIES ON THE MECHANISM OF ACTION OF METHOTREXATE AND CYCLOPHOSPHAMIDE ON CONTACT SENSITIVITY IN THE GUINEA PIG

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

14 June 2024

Molecular Pharmacology

9

41

671

Dayton

1992

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

The use of leflunomide in transplantation immunology

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Rapamycin blocks IL-2-driven T cell cycle progression while preserving T cell survival

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Immunopharmacology of rapamycin

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Immunosuppressive drugs and the induction of transplantation tolerance

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Tyrphostins and other tyrosine kinase inhibitors

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Identification of N,1,4,4-tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a potent, orally available cyclin dependent kinase inhibitor

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

14 June 2024

24

63

3612

Theti

2003

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical models

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

The binding of trimethoprim to bacterial dihydrofolate reductase

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Differential regulation of T-cell growth by IL-2 and IL-15

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

14 June 2024

39

461

Pedro

2001

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BMC.2010.07.004

14 June 2024

Identifiers

1 reference

13 September 2017

1 reference